Back to ListTarget Eluting Coronary Stent System

Firehawk® Rapamycin Target Eluting Coronary Stent System

Firehawk® Rapamycin Target Eluting Coronary Stent System is the World's First and Only Target Eluting Stent (TES), which is the new generation product of Shanghai MicroPort Medical (Group) Co., Ltd. following the Firebird and Firebird2 stent to treat coronary artery stenosis or occlusion disease.


  • Adopted the platform of TES Technology®
    Coating exposed area is only 5% of the stent surface
    Drug in-vivo released over 90 days
    Polymer fully absorbed in 9 months
    Average Metal Coverage Rate14.0-16.1%
    World's lowest drug dosage stent, with only 1/3 dosage versus similar products while achieving the same efficacy
Stent Length
( mm )
Stent Diameter ( mm )
2.25 2.50 2.75 3.00 3.50 4.00
13 RV2213 RV2513 RV2713 RV3013 RV3513 RV4013
16 RV2216 RV2516 RV2716 RV3016 RV3516 RV4016
18 RV2218 RV2518 RV2718 RV3018 RV3518 RV4018
21 RV2221 RV2521 RV2721 RV3021 RV3521 RV4021
23 RV2223 RV2523 RV2723 RV3023 RV3523 RV4023
26 RV2226* RV2526 RV2726 RV3026 RV3526 RV4026
29 RV2229* RV2529 RV2729 RV3029 RV3529 RV4029
31 -- RV2531 RV2731 RV3031 RV3531 RV4031
33 -- RV2533 RV2733 RV3033 RV3533 RV4033
35 -- -- RV2735* RV3035 RV3535 RV4035*
38 -- -- RV2738* RV3038 RV3538 RV4038*

All sizes approved by CFDA except *

1. EuroIntervention 2013; 9:75-83

2. Catheterization and Cardiovascular Interventions 2015; 85:734

3. Chin Med J 2012;125(6):970-976

4. Presented by Bo Xu MD, 2016 CIT

Contact Us

  • If you have any query about the product information, please contact our International Business Department: